Another study identified Akkermansia muciniphila to be correlated with better clinical response to anti-PD-1 therapy in patients with non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC) (19). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.